CLINICAL_TRIALS
ClinicalTrials.gov record update
An Exploratory Clinical Study on the Safety and Efficacy of CD19/BCMA Chimeric Antigen Receptor NK Cells in the Treatment of B Cell-related Autoimmune Diseases in Children
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06792799
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:54.930356+00:00
- Published At
- 2025-12-01T00:00:00+00:00
- Record Updated At
- 2025-12-01
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Autoimmune Diseases", "Systemic Lupus Erthematosus", "Multi-Drug Resistant Nephrotic Syndrome", "IgAN - IgA Nephropathy"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-12-01"- protocolSection.identificationModule.nctId
"NCT06792799"- protocolSection.identificationModule.officialTitle
"An Exploratory Clinical Study on the Safety and Efficacy of CD19/BCMA Chimeric Antigen Receptor NK Cells in the Treatment of B Cell-related Autoimmune Diseases in Children"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["EARLY_PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.